Arrowhead to accounce 1Q14 financial result on Feb 4
Arrowhead, Arc 520's researcher, is due to publish its 1Q14 (first quarter 2014) financial result on Feb 4th. Below are phone numbers to listen in. I have read through its 4Q13 result, which took place on Dec 18 2013. The management did not talk about anything we did not know back then, of course, but offered a lot of details that weren't available in previous conference publications.
As a stocks analyst, I know that listed companies tend to report good things only during such earnings conference, but at least they are not allowed to lie. Q&A sessions usually offers good value too, because the fellow analysts are usually very professional and they ask good questions.
Hope they offer some useful update this time.
Here is the link to its 4Q13 conference transcript, is an interesting read for those have time.
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will report its financial results for the fiscal 2014 first quarter ended December 31, 2013, on Tuesday, February 4, 2014, at 4:30 p.m. Eastern time. To participate in the conference call, please dial 877-300-8521 (toll free from the US), 855-669-9657 (toll free from Canada), or 412-317-6026 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at http://www.arrowheadresearch.com/presentations.
A replay of the webcast will be available approximately one hour after the conclusion of the call and will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be available for 30 days. The audio replay can be accessed by dialing 877-870-5176 (toll free from the US and Canada), or 858-384-5517 (for international callers) and entering Event ID 10040388.
I am in Hong Kong. We are seeing a doctor hopefully soon in the hospital that we know should be the place where the ARC-520 trials are taking place. We will try to ask the doctor about any update, should he be willing to talk.
The hospital is a public hospital, so it's extremely slow. Hope we got a slot soon.
I can't recall any concerns regarding ARC520 as I am not an expert. Studyforhope did raise many concerns, one was silencing of antigens production will lead to "lights turning off the Xmas tree". I am always hopeful until clinical trials prove otherwise.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.